Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.-论文-万方医学网

作者： Junichi,Koike ^[1] ; Kimihiko,Funahashi ^[2] ; Kazuhiko,Yoshimatsu ^[3] ; Hajime,Yokomizo ^[4] ; Hayato,Kan ^[5] ; Takeshi,Yamada ^[4] ; Hideyuki,Ishida ^[5] ; Keiichiro,Ishibashi ^[4] ; Yoshihisa,Saida ^[6] ; Toshiyuki,Enomoto ^[4] ; Kenji,Katsumata ^[6] ; Masayuki,Hisada ^[4] ; Hirotoshi,Hasegawa ^[7] ; Keiji,Koda ^[4] ; Takumi,Ochiai ^[7] ; Kazuhiro,Sakamoto ^[4] ; Hiroyuki,Shiokawa ^[8] ; Shimpei,Ogawa ^[4] ; Michio,Itabashi ^[8] ; Shingo,Kameoka ^[4]

作者单位： Department of Gastroenterological Surgery, Omori Medical Center, Toho University School of Medicine, 6-11-1 Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan. jkoike18@med.toho-u.ac.jp. ^[1] FACT Trial Group, Tokyo, Japan. jkoike18@med.toho-u.ac.jp. ^[2] Department of Gastroenterological Surgery, Omori Medical Center, Toho University School of Medicine, 6-11-1 Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan. ^[3] FACT Trial Group, Tokyo, Japan. ^[4] Department of Surgery, Tokyo Women's Medical University Medical Center East, Tokyo, Japan. ^[5] Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan. ^[6] Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan. ^[7] Department of Surgery, Toho University Ohashi Medical Center, Tokyo, Japan. ^[8] Department of Digestive Surgery and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan. ^[9] Department of Surgery, Keio University School of Medicine, Tokyo, Japan. ^[10] Department of Surgery, Teikyo University Chiba Medical Center, Chiba, Japan. ^[11] Department of Surgery, Tobu Chiiki Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation, Tokyo, Japan. ^[12] Department of Coloproctological Surgery, Faculty of Medicine, Juntendo University, Tokyo, Japan. ^[13] Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan. ^[14]

主题词成年人(Adult);老年人(Aged);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);综合疗法(Combined Modality Therapy);女(雌)性(Female);氟尿嘧啶(Fluorouracil);人类(Humans);输注, 静脉内(Infusions, Intravenous);醛氢叶酸(Leucovorin);男(雄)性(Male);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);肿瘤分期(Neoplasm Staging);有机铂化合物(Organoplatinum Compounds);手术后并发症(Postoperative Complications);前瞻性研究(Prospective Studies);直肠肿瘤(Rectal Neoplasms);体层摄影术, X线计算机(Tomography, X-Ray Computed)

DOI 10.1007/s00280-017-3243-7

PMID 28150022

发布时间 2022-03-21

检索历史清除

Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.

Cancer chemotherapy and pharmacology

相似文献

Cancer chemotherapy and pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.

Cancer chemotherapy and pharmacology

相似文献

Cancer chemotherapy and pharmacology

相关期刊

检索历史清除